Ultratech recently posted its Q4 Results with strong QoQ performance both on the Revenue and Net profit front, following which Jeferries has increased its target on the Stock
Brokerage Target and Rationale
Jefferies has maintained a Buy call on Ultratech Cement shares following its Q4FY25 results with a target price of Rs. 14,000, which is an Upside of 17.89 percent from the current market price of Rs. 11,875. The earlier target given by Jefferies was Rs. 13,265.
The brokerage states that in Q4FY25 results, Ultratech had shown good EBTDA growth after a continuous decline in the past three quarters. Jefferies also expects improvement in unit EBITDA for the acquired capacities from recent acquisitions, and the Q1 of FY26 could see benefits from the recent uptick in pricing.
Financial Highlights
The company reported a 12.94 percent YoY increase in revenue from Rs. 20,419 Crore in Q3FY24 to Rs. 23,063 Crore in Q3FY25. On a QoQ basis, the company reported an increase of 29.72 percent in revenue from Rs. 17,779 Crore in the previous quarter.
Their Net profit saw an increase of 9.56 percent YoY from Rs. 2,259 Crore to Rs. 2,475 Crore for the same period. On a QoQ basis, the company reported an impressive increase of 81.58 percent in Net profit from Rs. 1,363 Crore in the previous quarter.
About the Company
UltraTech Cement Limited is the largest cement company in India and a part of the Aditya Birla Group. It manufactures a wide range of construction materials, including grey cement, white cement, and ready-mix concrete.
The company has a strong presence across India and also operates in international markets. Known for its focus on quality, innovation, and sustainability, UltraTech plays a key role in infrastructure and real estate development and continues to expand its footprint through strategic investments and diversification into allied building material segments.
Written By Abhishek Das
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
